Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 12:22 AM
NCT ID:
NCT04132258
Eligibility Criteria:
Inclusion Criteria:
* Adult patient (\> 18 years of age),
* Biotherapy treatment: anti TNF, ustekinumab, secukinumab, ixekizumab, Rituximab, vedolizumab, abatacept, inhibitor jak kinase, anti Il1, Anti Il6,
* Biotherapy treatment \> 3 months,
* Chronic inflammatory disease: psoriasis, ankylosing spondylitis (SPA), rheumatoid arthritis (RA), Crohn's disease (CD), bleeding rectocolitis (HRC)
* No opposition to the study
Exclusion Criteria:
* Patient under legal protection measure,
* Refusal of the subject to participate in the study,
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04132258
Study Brief:
Protocol Section:
NCT04132258